SCOPUS 정보 검색 플랫폼

Volumn 56, Issue 4, 2002, Pages 289-291

Prophylaxis of respiratory syntical virus infections with palivizumad;Profilaxis de las infecciones por el virus respiratorio sincitial con palivizumab

(2) Danes Carreras I a Arnau de Bolos J Ma a

a HOSPITAL UNIVERSITARI VALL D HEBRON (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

COST EFFECTIVENESS ANALYSIS; EDITORIAL; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SPAIN; VIRUS INFECTION;

AGE FACTORS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CLINICAL TRIALS; COHORT STUDIES; COST-BENEFIT ANALYSIS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MULTICENTER STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS;

EID: 0036324570 PISSN: 03024342 EISSN: None Source Type: Journal
DOI: None Document Type: Editorial

Times cited : (5)

References (12)

1
- 0031683919
- Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
- (1998) Pediatrics , vol.102 , pp. 531-537

2
- 0034971499
- Safety and tolerance of palivizumab administration in a large Northern Hemisphere trial
- (2001) Pediatr Infect Dis J , vol.20 , pp. 628-630
- Groothuis, J.R.¹

3
- 0032881631
- Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants
- (1999) Pediatrics , vol.104 , pp. 419-427
- Joffe, S.¹ Ray, G.T.² Escobar, G.J.³ Black, S.B.⁴ Lieu, T.A.⁵

4
- 0033652584
- Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: A cost-effectiveness analysis
- (2000) Clin Ther , vol.22 , pp. 1357-1369
- Lofland, J.H.¹ Touch, S.M.² O'Connor, J.P.³ Chatterton, M.L.⁴ Moxey, E.D.⁵ Paddock, L.E.⁶

5
- 0033051532
- Impact of palivizumab on expected costs of respiratory syncytial virus infection in preterm infants: Potential for savings
- (1999) Clin Ther , vol.21 , pp. 752-766
- Marchetti, A.¹ Lau, H.² Magar, R.³ Wang, L.⁴ Devercelli, G.⁵

6
- 0034105390
- Respiratory syncytial virus immunoprophylaxis. Impact on epidemiology
- (2000) Paediatr Drugs , vol.2 , pp. 127-132
- Dougherty, N.N.¹ Meissner, H.C.²

7
- 0035063956
- Prophylaxis for respiratory syncytial virus infection: Missing the target
- (2001) Arch Dis Child , vol.84 , pp. 375
- Buck, J.J.¹ Debenham, P.² Tasker, R.C.³

8
- 0032853323
- Rehospitalization for respiratory syncytial virus among preterm infants
- (1999) Pediatrics , vol.104 , pp. 894-899
- Joffe, S.¹ Escobar, G.J.² Black, S.B.³ Armstrong, M.A.⁴ Lieu, T.A.⁵

9
- 0033979533
- Respiratory syncytial virus and premature infants born at 32 week's gestation or earlier. Hospitalization and economic implications of prophylaxis
- (2000) Arch Pediatr Adolesc Med , vol.154 , pp. 55-61
- Stevens, T.P.¹ Sinkin, R.A.² Hall, C.B.³ Maniscalco, W.M.⁴ McConnochie, K.M.⁵

10
- 0033846779
- Hospitalization rates for RSV infection in ex-preterm infants-implications for use of RSV immunoglobulin
- (2000) Arch Dis Child , vol.83 , pp. 122-127
- Thomas, M.¹ Bedford-Russell, A.² Sharland, M.³

11
- 0034821962
- Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons
- (2001) Pediatr Infect Dis J , vol.20 , pp. 874-879
- Carbonell-Estrany, X.¹ Quero, J.²

12
- 0031682215
- Humanized monoclonal antibody for prevention of respiratory syncytial virus infection
- (1998) Pediatrics , vol.102 , pp. 648-651
- Storch, G.A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.